Eminent Spine, a Georgetown, Texas-based medical device company, has recently completed and released the results of a study of its King Cobra Anterior Cervical Plate in which none of the 25 patients experience complications.
Israel-based medical device company Expanding Orthopedics has launched a post-market study in Europe to assess its XPED Expanding Pedicle Screw System for spinal fusion. The study will enroll up to 50 patients and test the usability of the products for 24 months postoperatively.
Anderson Orthopaedic Research Institute has partnered with the Cleveland-based medical device company ImageIQ for joint replacement research using three dimensional imaging analytics to enhance orthopedic implant wear studies. The data generated from the research will be used to reduce the frequency of joint replacement implant failures and improve the quality of life for patients.
InVivo Therapeutics recently released data supporting the use of its technology for treating spinal cord injuries in rodent models. The company's proprietary biopolymer scaffold showed positive preliminary data indicating a therapeutic effect in the rodent model. The company has proposed a 10-patient pilot study in humans with acute spinal cord injury, which could begin as early as next year pending approval from the FDA.
Atlanta-based orthopedic device company MedShape Solutions has received the Small Business Innovation Research Phase I grant from the National Institutes of Health to support research and development with its compliant shape memory device for meniscal repair. Paired with potential additional funding phases, the grant could total more than $1.5 million if the company achieves target Phase I development milestones.
Neuralstem, a Rockville, Md.-based medical device company, recently received FDA approval to advance its trial treating patients with amyotrophic lateral sclerosis in the cervical as well as the lumbar spine. Thus far, 12 patients have received the injection in the lumbar spine and show no signs of complications or disease acceleration.
The United States Army Telemedicine & Advanced Technology Research Center has given Semprus BioSciences a $1 million grant for orthopedic device research and development. The company will develop the first orthopedic devices designed to reduce biofilm formation after implantation.
German medical device company Ulrich is now using Zwick GmbH to test servo-hydraulic fatigue for quality control and development of its spinal implants. The testing will make sure implants are strong and reliable, with tests that can simulate the effects of posture change on implants.
Related Articles on Orthopedic Devices:
Arthrosurface Launches First Ankle Resurfacing System
Wright Medical Group Names Julie Tracy Senior Vice President, Chief Communications Officer
More Insurance Companies Now Reimburse for TranS1's AxiaLIF
Anderson Orthopaedic Research Institute has partnered with the Cleveland-based medical device company ImageIQ for joint replacement research using three dimensional imaging analytics to enhance orthopedic implant wear studies. The data generated from the research will be used to reduce the frequency of joint replacement implant failures and improve the quality of life for patients.
InVivo Therapeutics recently released data supporting the use of its technology for treating spinal cord injuries in rodent models. The company's proprietary biopolymer scaffold showed positive preliminary data indicating a therapeutic effect in the rodent model. The company has proposed a 10-patient pilot study in humans with acute spinal cord injury, which could begin as early as next year pending approval from the FDA.
Atlanta-based orthopedic device company MedShape Solutions has received the Small Business Innovation Research Phase I grant from the National Institutes of Health to support research and development with its compliant shape memory device for meniscal repair. Paired with potential additional funding phases, the grant could total more than $1.5 million if the company achieves target Phase I development milestones.
Neuralstem, a Rockville, Md.-based medical device company, recently received FDA approval to advance its trial treating patients with amyotrophic lateral sclerosis in the cervical as well as the lumbar spine. Thus far, 12 patients have received the injection in the lumbar spine and show no signs of complications or disease acceleration.
The United States Army Telemedicine & Advanced Technology Research Center has given Semprus BioSciences a $1 million grant for orthopedic device research and development. The company will develop the first orthopedic devices designed to reduce biofilm formation after implantation.
German medical device company Ulrich is now using Zwick GmbH to test servo-hydraulic fatigue for quality control and development of its spinal implants. The testing will make sure implants are strong and reliable, with tests that can simulate the effects of posture change on implants.
Related Articles on Orthopedic Devices:
Arthrosurface Launches First Ankle Resurfacing System
Wright Medical Group Names Julie Tracy Senior Vice President, Chief Communications Officer
More Insurance Companies Now Reimburse for TranS1's AxiaLIF